524156 TCMLMTD

TCM Share Price

 

 

Start SIP in TCMLMTD

Start SIP

Performance

  • Low
  • ₹56
  • High
  • ₹58
  • 52 Week Low
  • ₹35
  • 52 Week High
  • ₹81
  • Open Price₹57
  • Previous Close₹58
  • Volume972
  • 50 DMA₹61.22
  • 100 DMA₹56.99
  • 200 DMA₹52.13

Investment Returns

  • Over 1 Month -13.08%
  • Over 3 Month + 32.11%
  • Over 6 Month + 36.48%
  • Over 1 Year + 25.46%

Smart Investing Starts Here Start SIP with TCM for Steady Growth!

Invest Now

TCM Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 306
  • PEG Ratio
  • 2.7
  • Market Cap Cr
  • 43
  • P/B Ratio
  • 1.6
  • Average True Range
  • 2.93
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.24
  • RSI
  • 34.94
  • MFI
  • 55.73

TCM Financials

TCM Technicals

EMA & SMA

Current Price
₹58.10
+ 0.1 (0.17%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹61.37
  • 50 Day
  • ₹61.22
  • 100 Day
  • ₹56.99
  • 200 Day
  • ₹52.13

Resistance and Support

57.5 Pivot Speed
  • R3 61.38
  • R2 59.89
  • R1 58.99
  • S1 56.60
  • S2 55.11
  • S3 54.21

TCM Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-11 Quarterly Results
2025-08-11 Quarterly Results
2025-05-29 Audited Results
2025-02-10 Quarterly Results & Others To consider other business matters. issue of equity shares of Rs. 10/- each in the ratio of 6:5 @ premium of Rs. 15/-.
2024-11-12 Quarterly Results

TCM F&O

TCM Shareholding Pattern

49.51%
7.41%
38.79%
4.29%

TCM FAQs

TCM share price is ₹58 As on 17 January, 2026 | 13:15

The Market Cap of TCM is ₹43.4 Cr As on 17 January, 2026 | 13:15

The P/E ratio of TCM is 306 As on 17 January, 2026 | 13:15

The PB ratio of TCM is 1.6 As on 17 January, 2026 | 13:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23